← Open Payments lookup

DENISE KEENE: Open Payments

NPI 1457830770 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,590 in 92 payments from 10 companies in 2025. Trend: 2023 $1,088 · 2024 $389 · 2025 $1,590

Food & beverage: $1,359Education: $231
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.31$546
E.R. Squibb & Sons, L.L.C.33$401
Neurocrine BioSciences, Inc.5$156
Vanda Pharmaceuticals Inc.7$152
Janssen Pharmaceuticals, Inc4$93
Alkermes, Inc.4$77
Otsuka America Pharmaceutical, Inc.4$76
ABBVIE INC.2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
Luye Pharma (USA) Ltd.1$24

Products named: COBENFY, UZEDY, INGREZZA, FANAPT, AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.